Zobrazeno 11 - 20
of 659
pro vyhledávání: ''
Autor:
Bülent Deveci, Emine Gazi
Publikováno v:
Angiology. 72(2)
The albumin to globulin ratio (AGR) is used as a prognostic marker in acute ischemic cardiovascular events. We investigated whether serum AGR, fibrinogen, and fibrinogen to albumin ratio (FAR) are related to the presence and severity of coronary arte
Publikováno v:
Angiology. 73:5-6
Publikováno v:
Angiology. 72(1)
Structural aspects of red blood cells have been associated with cardiovascular disease. No data linking mean corpuscular volume (MCV) to clinical outcomes and on-treatment platelet reactivity in patients with peripheral artery disease (PAD) are avail
Autor:
Petra Buzkova, Christina L. Wassell, Suzette J. Bielinski, Nicholas B. Larson, Parveen K. Garg, Matthew A. Allison, Michael H. Criqui
Publikováno v:
Angiology
Angiology, vol 71, iss 6
Angiology, vol 71, iss 6
Higher levels of hepatocyte growth factor (HGF) have been associated with the presence of peripheral arterial disease (PAD), but prospective associations are unknown. We examined the association of circulating HGF levels with incident PAD. Between 20
Autor:
Alan A. Sag, Mehmet Kanbay, Onur Yilmaz, Dimitrie Siriopol, Adrian Covic, Baris Afsar, Nihan Erden, Patrick Rossignol, Masanari Kuwabara, Neris Dincer, Alberto Ortiz, David Z.I. Cherney
Publikováno v:
Angiology. 71(4)
Several trials have been completed in patients with heart failure (HF) treated with uric acid (UA)-lowering agents with inconsistent results. We aimed to investigate whether lowering UA would have an effect on mortality and cardiovascular (CV) events
Publikováno v:
Angiology. 70:62-68
Coronary artery ectasia (CAE) is a rare disease and a substantial portion of patients with CAE are first diagnosed with acute myocardial infarction (AMI). The question was raised if CAE was a kind of thrombotic disease. We assessed a consecutive seri
Autor:
Sofia Giannitsi, Athanasios J. Manolis, Manolis S. Kallistratos, Pavlos Tsinivizov, Leonidas E. Poulimenos
Publikováno v:
Angiology. 70:291-298
Trimetazidine (TMZ) is a metabolic agent with significant anti-ischemic properties. By inhibiting the terminal enzyme in the β-oxidation pathway, it shifts the energy substrate metabolism, enhancing glucose metabolism. Thus, it maintains the require
Autor:
Lidia Hategan, László Czopf, Péter Kupó, Margit Solymár, Péter Hegyi, Tamas Habon, Alexandra Bálint, Róbert Sepp, Beáta Csányi, Zsolt Szakács, Márta Balaskó, Gábor Varga, Annamária Tringer, János Borbás, András Komócsi
Publikováno v:
Angiology. 71(1)
We assessed the cardiovascular safety of long-term direct-acting oral anticoagulant (DOAC) treatment. A search of the medical literature was performed from inception until May 31, 2019. Inclusion criteria were (1) randomized trial that assessed the c
Autor:
Mauro Pennacchi, Gualtiero Palareti, Giuseppe Patti, Emilia Antonucci, Plinio Cirillo, Rossella Marcucci, Vittorio Pengo, for Eyeshot Study, Paolo Calabrò, Leonardo De Luca, Marco Di Maio, Felice Gragnano, Antonino Granatelli, Start Antiplatelet Register, Pasquale Pignatelli, Paolo Gresele, Stefano De Servi
Publikováno v:
Angiology. 69:795-802
The epidemiology and management of patients with acute coronary syndromes (ACSs) have evolved. We aimed to describe recent demographics and therapeutic changes in the Italian ACS population. We analyzed data from 2 multicenter consecutive Italian reg
Autor:
Thomas Gremmel, Renate Koppensteiner, Patricia P. Wadowski, Christoph W. Kopp, Simon Panzer, Silvia Lee
Publikováno v:
Angiology. 69:786-794
Low high-density lipoprotein cholesterol (HDL-C) levels are an independent predictor of ischemic events in patients with atherosclerotic cardiovascular disease. This may in part be due to decreased clopidogrel-mediated platelet inhibition in patients